ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
CATX Company Profile and Key Details
Perspective Therapeutics
Price Chart
Stock Price Today
Perspective Therapeutics, Inc. (CATX) stock surged +0.69%, trading at $3.92 on AMEX, up from the previous close of $3.89. The stock opened at $3.95, fluctuating between $3.90 and $3.95 in the recent session.
Stock Snapshot
Relevant Articles
SEC Fillings
Current Report (8-k)
Annual Report (10-k)
Stock Price History Chart
Contact Details
About Company
Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.
Company Information
| Employees | 138 |
| Beta | 1.12 |
| Sales or Revenue | $10.80M |
| 5Y Sales Change% | -0.509% |
| Fiscal Year Ends | June |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep